“@Merck is a pioneer in biocatalysis, improving manufacturing of crucial medicines. We're thrilled to be partnering with Merck, and to be leveraging our platform capabilities for improved enzyme activity and production.” - @jrkelly https://t.co/tGebaliX5m
“The most precious thing you have is your life energy and what you choose to pour it into. For the first time, we can see the path of how to design biology more systematically & address the problems we’re facing & create a better world.” - @reshmapshetty
https://t.co/sEmIEtLYvJ
Great interview with @ericschmidt on how synthetic biology tech improvement combined with AI advances are making the bioeconomy the next big area of tech growth 🌱🌱🌱
Excited to welcome Optimvia to our platform and support their program to produce biosynthetic heparin, an essential medicine now primarily produced from animal sources: https://t.co/uZyRiChpuf
Growing @Ginkgo from 5 founders to a publicly traded company $DNA has been quite the journey. Check out my fireside chat with @VertexPharma CEO and Ginkgo board member Reshma Kewalramani about leadership from #ginkgoferment https://t.co/TYAc2Uqgm6
We are so excited to announce to you all that we have partnered with the visionary @Ginkgo
A partnership like this is a significant milestone for us and will bring a tremendous amount of momentum to our work. Read all about it!
https://t.co/dBbJOO2bJi
Public-Private collaboration is absolutely critical to scaling 21st century biosecurity solutions… Appreciate the leadership from @CDCgov@CDCDirector in launching this program to watch for variants coming into the US. @Ginkgo@XpresCheck
https://t.co/ql5joXm9b0
At Ginkgo, we build your organism so that you can grow your product.
With CDKs, we’re making it even easier to get started!
Join us this morning for our virtual event, “Grow with Ginkgo: You're a Cell Developer” from 10-noon ET: https://t.co/TPQIAVtxGt
ICYMI: plant-based burgers made all the more delicious by some Ginkgo yeast-produced Hemami™. Check out this video and learn more about the incredible, meaty projects being developed at @motiffoodworks
https://t.co/WzFele0d5M
Congrats @Ginkgo (YC S14) on the huge milestone today, representing the largest-ever biotech go-public transaction.
Gingko is building the leading horizontal platform for cell programming, helping accelerate the development of solutions to the world's most pressing challenges.
Happy to announce that @Ginkgo's merger with $SRNG was approved this morning and at closing we will bring in ~$1.6 billion dollars in new capital to the company!!! 🧵
https://t.co/U0gZZRIHnN